Intellia Therapeutics Inc (NTLA)
Healthcare
Biotechnology
10.80 $
+0.8%
vs. previous close
Closing price · As of: 3. Aug 2026
Intellia Therapeutics Inc (NTLA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -349 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.5 | -1.8 | 36 | -65 | -61 | -103 | -50 | -225 | -333 | -394 | -349 | -349 | |
| 0.0 | 0.3 | 1.1 | 3.0 | 4.5 | 5.6 | 6.3 | 6.9 | 7.6 | 9.0 | 10 | 10 | |
| 0.5 | 1.3 | 6.7 | 15 | 17 | 15 | 20 | 47 | 91 | 134 | 154 | 154 | |
| 9.5 | 1.3 | 6.7 | 15 | 17 | 15 | 20 | 46 | 172 | – | – | – | |
| 1.0 | 10 | 60 | -16 | 3.2 | -21 | 58 | -23 | -54 | -52 | 12 | -74 | |
| 0.4 | 2.6 | 6.2 | 10 | 6.4 | 6.8 | 3.6 | 13 | 58 | 14 | 5.8 | 5.8 | |
| -0.9 | -2.6 | -6.2 | -10 | -261 | 25 | -214 | -551 | 160 | -31 | 126 | 126 | |
| – | – | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| 0.5 | -2.7 | -0.1 | 143 | 40 | 76 | 372 | 1,861 | 583 | – | – | – | |
| 19 | 70 | 167 | 143 | 40 | 76 | 372 | 737 | 583 | 130 | 186 | 186 | |
| 15 | 66 | 197 | 68 | -282 | -1.6 | 107 | -39 | 410 | -295 | -38 | -38 | |
| -3.9 | -4.3 | 30 | -75 | -68 | -110 | -53 | -238 | -392 | -408 | -355 | -355 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.